Haffkine Bio-Pharmaceutical Corporation Ltd. Manufactures Oral Poliomyelitis Trivalent Vaccine. Haffkine Bio-Pharmaceutical Corporation Ltd. Supplies wide range of bacterial and viral vaccines for diphtheria, tetanus, whooping cough, plague, poliomyelitis and rabies. Oral Poliomyelitis Trivalent Vaccine is a clear, transparent, yellowish orange to pink coloured solution. Oral Poliomyelitis Trivalent Vaccine contains suspension of types 1, 2 and 3 attenuated poliomyelitis viruses [Sabin strains] propagated in MRC5 cell cultures. This vaccine may contain trace amounts of Neomycin sulfate and Polymyxine B Sulfate. The vaccine fulfils WHO requirements for Oral Poliomyelitis Vaccine. It is indicated for active immunization of infants, susceptible children and adults against infection caused by polioviruses of Types 1, 2 & 3.
